MeSH tree: C19.246
Lifestyle-induced loss of visceral fat (and not liver fat, pancreatic fat or subcutaneous fat) may have lasting health benefits years after the end of an intervention, even when body weight is fully regained, according to ...
Jun 14, 2026
0
26
In people with type 2 diabetes, semaglutide was associated with a 15% reduction in bone fractures and greater weight loss compared with other anti-obesity medications, according to a study presented at ENDO 2026, the Endocrine ...
Jun 14, 2026
0
8
Origami masters turn simple sheets of paper into ornate sculptures. In the origami of life, our cells must fold proteins into specific three-dimensional shapes before they can carry out their biological jobs. This folding ...
Jun 14, 2026
0
12
The Inflation Reduction Act's attempt to improve insulin costs for Medicare beneficiaries—by capping out-of-pocket costs at $35—was associated with lower out-of-pocket costs and increased insulin use, but only for a small ...
Jun 14, 2026
0
3
People prescribed GLP-1 medications are more likely to start and stop than most people assume, according to a study presented at ENDO 2026, the Endocrine Society's annual meeting in Chicago.
Jun 14, 2026
0
4
Testosterone treatment may improve body composition, glucose metabolism and sexual desire in some older men at high risk of type 2 diabetes (T2D), but the benefits require engagement in a lifestyle program, according to a ...
Jun 13, 2026
0
5
The incidence of type 1 diabetes among teens in Puerto Rico more than doubled from 2009 to 2021 and remained elevated through 2024, with an average annual increase of 4.1%, according to a study presented at ENDO 2026, the ...
Jun 13, 2026
0
6
In a study exploring how an AI-assisted diagnostic tool shaped care for underserved populations at multiple community-based primary care sites, investigators at the Wilmer Eye Institute, Johns Hopkins Medicine, found that ...
Jun 13, 2026
1
6
For those scared of needles but who need GLP-1 receptor agonists to help manage their weight, there might be some good news. Researchers are testing a new oral, small-molecule GLP-1 receptor agonist called Elecoglipron, which ...
People with an organ transplant who develop or have existing diabetes are more likely to die than those without diabetes, according to a comprehensive analysis of solid-organ transplant recipients presented at ENDO 2026, ...
Jun 13, 2026
0
4
